Interaction of Cryptococcus neoformans Rim101 and Protein Kinase A Regulates Capsule by O'Meara, Teresa R. et al.
Interaction of Cryptococcus neoformans Rim101 and
Protein Kinase A Regulates Capsule
Teresa R. O’Meara, Diana Norton, Michael S. Price, Christie Hay, Meredith F. Clements, Connie B. Nichols,
J. Andrew Alspaugh*
Departments of Medicine and Molecular Genetics/Microbiology, Duke University School of Medicine, Durham, North Carolina, United States of America
Abstract
Cryptococcus neoformans is a prevalent human fungal pathogen that must survive within various tissues in order to
establish a human infection. We have identified the C. neoformans Rim101 transcription factor, a highly conserved
pH-response regulator in many fungal species. The rim101D mutant strain displays growth defects similar to other fungal
species in the presence of alkaline pH, increased salt concentrations, and iron limitation. However, the rim101D strain is also
characterized by a striking defect in capsule, an important virulence-associated phenotype. This capsular defect is likely due
to alterations in polysaccharide attachment to the cell surface, not in polysaccharide biosynthesis. In contrast to many other
C. neoformans capsule-defective strains, the rim101D mutant is hypervirulent in animal models of cryptococcosis. Whereas
Rim101 activation in other fungal species occurs through the conserved Rim pathway, we demonstrate that C. neoformans
Rim101 is also activated by the cAMP/PKA pathway. We report here that C. neoformans uses PKA and the Rim pathway to
regulate the localization, activation, and processing of the Rim101 transcription factor. We also demonstrate specific host-
relevant activating conditions for Rim101 cleavage, showing that C. neoformans has co-opted conserved signaling pathways
to respond to the specific niche within the infected host. These results establish a novel mechanism for Rim101 activation
and the integration of two conserved signaling cascades in response to host environmental conditions.
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Introduction
All cells, including pathogenic microorganisms, must be able to
sense and respond to changes in their environment. As these cells
enter a human host, they need to protect themselves from the
immune system and rapidly adapt to human physiologic
conditions, such as low nutrient availability, varying pH, and
mammalian concentrations of carbon dioxide [1]. Therefore, they
must coordinate multiple signaling pathways in order to control
appropriate cellular responses.
One of the most common environmental stresses for pathogenic
fungi is a change in the extracellular pH. Alterations in pH can
affect a large number of cellular processes including membrane
and cell wall stability, morphogenesis, protein stability and
function, and nutrient uptake [2–8]. Many of these responses to
pH are regulated by the Rim101 transcription factor and its
homologues (PacC in filamentous fungi). Additionally, many
pathogenic fungi respond to the neutral or slightly alkaline pH
of the host by inducing virulence-associated phenotypes [2,9–14].
Therefore, in diverse fungi such as Aspergillus and Candida species,
mutants defective in pH sensing/response no longer induce
phenotypes associated with virulence in pathogenic species. For
example, C. albicans rim101D/D mutants do not undergo pH-
dependent dimorphic switching, do not appropriately increase
uptake of iron, and do not secrete the proteases and phosphatases
necessary for invasion of host tissues [3,5,15–19]. A. nidulans pacC
(rim101) mutants display decreased growth, decreased secondary
metabolite production, and defective invasive growth [9,14,20–22].
Although A. nidulans is non-pathogenic, these cellular processes have
been associated with virulence in other Aspergillus species.
In addition to the direct effects of ambient pH on cell integrity
and various metabolic processes, pH changes also affect nutrient
uptake. For example, under alkaline conditions, the availability of
free iron is greatly reduced as the iron equilibrium shifts from the
bioavailable ferrous form to the insoluble ferric form. Studying iron
flux is an important new horizon in fungal pathogenesis, as the
human host keeps free iron levels at extremely low concentrations
(10
218M) through constitutively expressing iron-binding proteins
such as transferrin and lactoferrin. In this way, the host protects
against invading microorganisms. Fungal pathogens unable to
increase iron uptake in this iron-limited host environment often
have severe defects in virulence [5,23–26]. The pH-responsive
Rim101 transcription factor is involved in the regulation of iron
homeostasis, directly binding to the promoters of genes encoding
high affinity iron uptake proteins: iron transporters, iron permeases
and siderophore transporters [20,23,27].
Cryptococcus neoformans is an opportunistic human fungal
pathogen. Unlike the distantly related pathogens Candida albicans
or Aspergillus fumigatus, C. neoformans grows within a very narrow
range of pH values in the host. It grows well at the human
physiological pH of the blood and cerebrospinal fluid (pH 7.4) as
well as in acidic environments such as the phagolysosome of the
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fumigatus, C. neoformans demonstrates a severe growth defect above
pH 8. Despite this increased sensitivity to alkaline pH, there is still
evidence that C. neoformans responds to the slightly alkaline pH of
the infected host blood by inducing virulence-associated pheno-
types. Capsule production, a major virulence determinate, is
optimal at human physiological pH [28,30–32].
On a molecular level, C. neoformans capsule synthesis is tran-
scriptionally regulated by elements of the cAMP/PKA pathway.
Strains with mutations in core cAMP signaling elements (such as the
Gpa1 Ga protein, adenylyl cyclase Cac1, or the PKA catalytic
subunit Pka1) display defective expression of capsule, and these
mutant strains are attenuated for virulence in animal models of
cryptococcosis. When the regulatory subunit of PKA is mutated in
the pkr1D strain, the cells have constitutive activation of PKA
signaling and display high production of capsule, even in non-
inducing conditions [33–38]. Other inducing conditions for capsule
include iron deprivation, nutrient limitation, and the presence of
serum. The mechanisms by which these environmental signals are
sensed and subsequently transduced to specific intracellular signaling
pathways are not yet known. To explore the interaction of the
inducing environmental signals, signal transduction pathways, and
downstream effectorscontrollingcapsule synthesis,wehavebegunto
characterize specific transcription factors that are predicted to be
targeted by the cAMP pathway, and which also directly control
capsule gene expression. By examining the biological function and
regulation of the C. neoformans Rim101 homolog transcription factor,
we have determined a new pathway for C. neoformans regulation of
capsule production. We have also defined a novel interaction
between the highly conserved Rim and PKA signaling pathways.
Results
Identifying PKA-regulated transcription factors
To identify potential transcriptional regulators of C. neoformans
capsule that are also directly phosphorylated by PKA, we used a
bioinformatic survey of the annotated C. neoformans genome. We
first searched the available annotation (GO terms, gene names,
homology designators) for proteins likely to be involved in
transcriptional regulation: transcription factors, DNA binding
motifs, zinc finger domains, and other transcriptional regulators.
Given the incomplete annotation of the genome, we accepted that
many transcriptional regulators might be initially misidentified or
excluded by this approach.
Among this subset of proteins, we searched the predicted
protein sequence for consensus sequences for PKA phosphoryla-
tion (R/K R/K X S/T), to identify potential direct targets of the
Protein Kinase A enzyme. One of these proteins is a homologue of
Rim101/PacC, a conserved fungal C2H2 transcription factor
(GenBank ID CNH00970). The C. neoformans Rim101 protein
contains a RRASSL motif at aa730, and has highest homology to
Aspergillus nidulans PacC in the C2H2 domain. Analysis of the
protein for conserved domains revealed that the only significant
Pfam-A match is the zinc finger C2H2 domain (aa133–155).
Disruption of RIM101
To characterize the biological role of this C. neoformans
transcriptional regulator, we disrupted the C. neoformans RIM101
gene by homologous recombination. Southern blot analysis
confirmed that the rim101::nat mutant allele precisely replaced
the native gene in the rim101D deletion strain (TOC2) (Table 1)
without additional ectopic integration events (data not shown). In
addition to this mutant strain in which the entire RIM101 open
reading frame was deleted, we created an independent rim101D
mutant with a partial gene deletion. All phenotypes between these
strains were identical, and the TOC2 strain was therefore chosen
as the representative rim101D mutant strain. To ensure that any
phenotypes observed in the rim101D mutant strain were due to
disruption of the RIM101 gene, we created a rim101D+RIM101
complemented strain (TOC4) by integrating a wild-type copy of
the RIM101 gene into the genome of the rim101D mutant strain.
The rim101D mutant strain grew at a similar rate as wild-type
on rich media (YPD) and minimal media (YNB) at 30uC, 37uC
and 39uC. We found no defect in melanin production on Niger-
seed medium. We also examined the mutant strain for resistance
to hydrogen peroxide and paraquat by disc diffusion assays and
established that the zone of inhibition for the rim101D mutant
strain was similar to that of wild-type, showing no additional
sensitivity to reactive oxygen species.
Rim101 is required for capsule induction
The rim101D mutant strain has a major defect in polysaccharide
capsule, an important virulence factor in C. neoformans.W e
incubated wild-type and rim101D mutant strains in a capsule
inducing medium, Dulbecco’s modified Eagle’s medium (DMEM)
containing 25 mM NaHCO3, for 72 hrs at 37uC and 5% CO2.
Table 1. List of strains used in this study.
Name Genotype Reference
H99 Wild-type [90]
TOC 2 rim101::nat this paper
TOC 4 rim101::nat RIM101-neo this paper
TOC 10 rim101::nat + pHIS-Gfp-Rim101-neo this paper
TOC 12 ura5 pka1::URA5 + pHIS-Gfp-Rim101-neo this paper
TOC 13 ura5 pkr1::URA5 + pHIS-Gfp-Rim101-neo this paper
TOC 17 rim20::nat this paper
TOC 21 rim20::nat + pHIS-Gfp-Rim101-neo this paper
TOC 18 rim101::nat + pHIS-Gfp-Rim101-S773A-neo this paper
TOC 20 ura5 pkr1::URA5 + pHIS-Gfp-Rim101-S773A-neo this paper
TOC 22 rim20::nat: + pHIS-Gfp-Rim101-S773A-neo this paper
JKH 7 ura5 pka1::URA5 [91]
CDC 7 ura5 pkr1::URA5 [36]
TYCC 33 ade2 cap59::ADE [92]
doi:10.1371/journal.ppat.1000776.t001
Author Summary
Cryptococcus neoformans is an environmental fungus and an
opportunistic human pathogen. Survival of this fungus
within a human host depends on its ability to sense the host
environment and respond with protective cellular changes.
It is known that the cAMP/PKA signal transduction cascade
is important for sensing host-specific environments and
regulating the cellular adaptations, such as capsule and
increased iron uptake, that are necessary for growth inside
the infected host. Here we document that, unlike what has
been described in other fungal species, a C. neoformans
Rim101 homologueisdirectly regulated byPKA. TheRim101
signaling pathway is also involved in capsule regulation and
virulence. Our study demonstrates that Rim101 integrates
two conserved signal transduction cascades, and it is
important in regulating microbial pathogenesis.
C. neoformans Rim101
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capsules surrounding each cell which can be quantitatively
measured by analyzing the percent packed cell volume (Cryptocrit
analysis) [31]. The rim101D mutant strain exhibits markedly
reduced capsule around the cell (3.6% packed cell volume)
compared to the wild-type strain (6.2% packed cell volume). The
rim101D mutant capsule-defective phenotype was not noted in
previous reports of the C. neoformans Rim101 protein [39];
therefore, we confirmed our observation in several ways. We
examined several independent rim101D mutants, including partial
and complete gene deletions, which all displayed similar capsule
defects in the inducing conditions. These differences in capsule
were microscopically visualized by the exclusion of India ink
(Figure 1A). Reintroduction of the wild-type allele fully comple-
mented the capsule phenotype (6.8% packed cell volume).
To confirm the role of Rim101 and the Rim pathway in C.
neoformans capsule production, we searched the C. neoformans
genome for conserved elements of the Rim pathway, and we
identified the RIM20 gene. Rim20 is a scaffold protein required for
Rim101 cleavage/activation in other fungal species [6,40–45].
When we mutated this gene, we observed a similar capsule defect
in the rim20D mutant compared to the rim101D mutant strain
(Figure 1A).
C. neoformans capsule is secreted out of the cell and subsequently
bound to the cell wall [46]. To determine whether rim101D mutant
strains produce and secrete capsular polysaccharide, we used a
previously described gel electrophoresis technique to quantify this
polymer [47]. C. neoformans cells were incubated in capsule-
inducing DMEM for 1 week, after which polysaccharide that was
shed into the medium was analyzed for relative abundance and
size by reactivity against an anti-GXM antibody (mAb18B7). We
noted a similar amount of secreted polysaccharide in the rim101D
mutant as wild-type (Figure 1B) suggesting that there is no
significant GXM synthesis defect in the rim101D strain. We
repeated this assay using low iron medium [31] as the capsule
inducing condition instead of Dulbecco’s modified Eagle’s
medium, and we again observed a similar amount of secreted
capsule in wild-type and rim101D mutant strains (Figure 1B). As
previously described, we used a cap59 mutant strain that is unable
to secrete capsule as a negative control [48] and detected no
capsule by this assay in this strain. We also demonstrated the
quantitative nature of this assay by analyzing the pka1D mutant
strain, in which there is a previously documented decrease in
capsule production compared to wild-type [36] (Figure 1B).
Therefore, the hypocapsular phenotype of the rim101D mutant
strain in the presence of intact polysaccharide production suggests
a defect in capsule attachment. This result is similar to the
phenotype of the C. neoformans ags1D mutant strain which can
synthesize and secrete capsule but cannot bind it [49,50].
CnRim101 retains conserved physiological roles with
Rim101/PacC from other fungal species
In fungi as diverse as Aspergillus, Saccharomyces, Candida, and
Ustilago species, the Rim101/PacC proteins control multiple pH-
related phenotypes, including regulating iron homeostasis; main-
taining membrane and cell wall-associated proteins; and secreting
proteases, secondary metabolites, and phosphatases [2,5,14,51].
Many of these factors are important in the virulence of pathogenic
fungi.
We tested the C. neoformans rim101D mutant strain to determine
if this protein retains conserved physiological roles with Rim101/
PacC proteins in other fungal species. On alkaline media, the
rim101D mutant strain exhibits a severe growth defect compared to
the wild-type and the reconstituted strains at alkaline pH above 7.6
(p,0.01) (Figure 2A). Similar to other rim101-defective fungal
strains, the C. neoformans rim101D mutant also displayed sensitivity
to media containing 200 mM LiCl or 1.5M NaCl (Figure 2B).
To confirm that this growth defect was due to specific sensitivity
to ionic stress as opposed to general sensitivity to osmotic stress,
we tested the cells for growth on media containing 2.5M sorbitol
and detected no difference in growth between the rim101D mutant
strain and wild-type. We also determined no defects in response to
cell wall stress for the rim101D mutant strain during growth on
calcofluor white, Congo red, or 0.05% SDS. These data suggests
that, unlike in other fungal species, there are no major defects in
cell wall integrity in the C. neoformans rim101D mutant strain.
Rim101 localization is regulated by PKA and Rim20
In other fungal species, the Rim101 protein is activated by
cleavage and subsequently localized to the nucleus, as expected for
a transcription factor [52]. To test whether C. neoformans Rim101 is
cleaved and localized to the nucleus, we created a Gfp-Rim101
fusion protein. We fused the green fluorescent protein gene to the
N-terminus of the RIM101 gene, expressing the new transgene
under control of a constitutive histone promoter. Introduction of
this plasmid (pTO2) by biolistic transformation into the rim101D
mutant strains fully complemented the rim101D mutant capsule
phenotype, indicating that the Gfp-Rim101 fusion protein is
functional (Figure 1C).
Unlike A. nidulans, in which localization is dependent on
activation, C. neoformans Rim101 is nuclear under all conditions
tested. Using epifluorescent microscopy, we observed a nuclear
pattern of localization for C. neoformans Gfp-Rim101 after 24 hours
growth in various conditions, including YNB buffered at pH 8,
Dulbecco’s modified Eagle’s medium, YNB (pH 5.4), and YPD
(Figure 3). In contrast, the Gfp-Rim101 protein in the pka1D and
rim20D mutant backgrounds localized to both the nucleus and the
cytoplasm under the same growth conditions, suggesting that PKA
activity and Rim20-mediated cleavage are both important for
complete nuclear localization (Figure 3). In addition, overexpres-
sion of the Gfp-tagged Rim101 protein was not able to suppress
the pka1D or the rim20D mutant capsule phenotype (Figure 1C).
To further explore the potential association of PKA and
Rim101, we mutated the single Rim101 consensus sequence for
PKA phosphorylation by changing serine 773 to an alanine,
creating the Rim101-S773A mutant protein encoded in plasmid
pTO3. When examining the localization of the Gfp-Rim101-
S773A protein, we observed both nuclear and cytoplasmic
fluorescence, similar to the localization of wild-type Gfp-Rim101
expressed in the pka1D and rim20D mutant backgrounds.
Introduction of the Gfp-Rim101-S773A protein into the rim20D
background also resulted in both nuclear and cytoplasmic
localization of Rim10. Additionally, the Rim101-S773A mutant
protein in the rim101D mutant background did not complement
the capsule phenotype (Figure 1D). This observation, coupled with
our documentation that some Gfp-Rim101-S773A protein is
localizing to the nucleus, indicates that serine 773 is necessary for
full function of the Rim101 protein. When we transformed the
Rim101-S773A mutant protein into the pkr1D mutant strain, in
which PKA signaling and capsule production are constitutively
active, multiple independent transformants had markedly attenu-
ated capsule, even though the wild-type RIM101 gene was still
present in these strains (Figure 1D). In contrast, introduction of
the plasmid containing the wild-type Rim101 fused to Gfp into the
pkr1D strain had no effect on capsule. This suggests that the
Rim101-S773A mutant protein is acting in a dominant negative
manner on C. neoformans capsule.
C. neoformans Rim101
PLoS Pathogens | www.plospathogens.org 3 February 2010 | Volume 6 | Issue 2 | e1000776Figure 1. C. neoformans Rim101 is required for capsule attachment. A. rim101D mutants have a capsule defect. Cells were incubated in capsule
inducing conditions for 3 days. Capsule was assessed by staining with India ink and visualizing the zone of exclusion at 636 magnification (scale
bar=10 m).B.Therim101Dmutantshedsequivalentcapsuletowild-type.Electrophoretic mobilityandquantityofshedpolysaccharidewasassessedby
a blotting technique of culture medium filtrate, using an anti-GXM antibody to probe for capsule as previously described [47]. Cells were incubated in
Dulbecco’s modified Eagle’s medium or low iron medium for 1 week before filtering. Arrow indicates direction of electrophoresis. C. Gfp-tagged Rim101
is functional. Cells were incubated in capsule inducing conditions for 3 days. Capsule was assessed by staining with India ink and visualizing the zoneo f
exclusion at 636magnification (scale bar=10 m). D. Rim101-S773A does not complement capsule. Cells were incubated in capsule inducing conditions
for 3 days. Capsule was assessed by staining with India ink and visualizing the zone of exclusion at 636magnification (scale bar=10 m).
doi:10.1371/journal.ppat.1000776.g001
C. neoformans Rim101
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To examine the interaction of PKA and the C. neoformans Rim
pathway, we used western blotting techniques to compare Rim101
protein processing in multiple strain backgrounds. Using an anti-
Gfp monoclonal antibody for detection, we identified bands
corresponding to the Gfp-Rim101 fusion protein from cell lysates
of cultures incubated in YPD to mid-log phase (Figure 4A). The
protein we detected when both Pka1 and Rim20 were wild-type
had a molecular weight of approximately 120kD (Figure 4A). In
contrast, expression of the identical Gfp-Rim101 fusion protein in
the pka1 or rim20D mutant backgrounds resulted in a protein band
of approximately 140kD, which is the predicted size of the full
length fusion protein. The Gfp-Rim101-S773A protein also
migrated with a reduced electrophoretic mobility in the rim101D
or rim20D backgrounds, resulting in an approximately 140kD
band. The 120kD processed form of Gfp-Rim101 was dependent
on both PKA and Rim20. Treatment with lambda phosphatases
did not alter the mobility of any of these bands (data not shown).
We also observed multiple smaller bands in the pka1D and rim20D
mutant backgrounds. These may represent degradation products,
suggesting that both Pka1 and Rim20 are necessary to prevent
aberrant proteosomal involvement [53]. In addition, the strains
with a 140kD Gfp-Rim101 protein were the same strains that had
both cytoplasmic and nuclear patterns of Gfp fluorescence. Only
the 120kD processed form had predominantly nuclear localization
(Figure 3).
A. nidulans PacC undergoes two successive cleavage events that
regulate its function as an alkaline-responsive transcription factor
[42,43,53,54]. To examine whether C. neoformans Rim101 also
undergoes a second cleavage event under activating conditions, we
incubated the rim101D +Gfp-RIM101 strain to mid-log phase in
either YPD or capsule inducing media. When incubated in
DMEM, we detected an additional band at approximately 70kD,
corresponding to a potentially cleaved N-terminal fragment of the
Rim101 protein (Figure 4B). This band was not present when
PKA, Rim20, or the PKA phosphorylation consensus sequence
were mutated, or under non-inducing conditions, demonstrating
that PKA phosphorylation and Rim20 are necessary for this
further cleavage of Rim101 under inducing conditions.
Rim101 downstream targets—capsule and iron
To define the downstream targets of the Rim101 transcription
factor, we performed comparative transcriptional profiling be-
tween the rim101D mutant strain and wild-type using whole
genome microarrays. We confirmed these results for several genes
using quantitative real-time PCR (data not shown). These results
indicate that Rim101 controls the transcription of many genes
involved in several categories of cellular function (Table 2).
Under capsule-inducing conditions, we were able to document
differential expression for a limited number of genes that may be
involved in capsule biosynthesis. We observed a 2.9-fold greater
expression of UGD1 in the wild-type compared to the rim101D
mutant strain. UGD1 encodes a UDP-glucose dehydrogenase that
is necessary for UPD-glucuronic acid synthesis and thus capsule
biosynthesis [55,56]. A mannosyltransferase (Cmt1) was 2.97-fold
greater expressed in the rim101D mutant strain than the wild-type.
Mannosyltransferases such as Cmt1 have been implicated in the
biosynthesis of GXM [57]. In addition, we observed a 3.2-fold
decrease in expression of a phosphomannomutase gene (PMM)i n
the rim101D mutant strain. PMM is involved in the biosynthesis of
GDP-mannose, another nucleotide sugar essential for capsule
production, and is transcriptionally regulated by PKA [24,58–61].
The data also show a small number of other nucleotide sugar-
related genes that are differentially expressed and may be involved
Figure 2. Rim101 retains conserved phenotypes from other
fungal species. A. The rim101D mutant is sensitive to alkaline pH. Cells
were incubated in buffered YNB, and growth was determined by cell
counts after 72 hours. B. The rim101D mutant is sensitive to salt stress.
1610
5 cells from each strain were serially diluted (5-fold dilution) onto
YPD plates containing 1.5M NaCl or 200 mM LiCl. The plates were
incubated at 30uC for 3 days. Cells were plated onto YPD plates for 48
hours as a control.
doi:10.1371/journal.ppat.1000776.g002
C. neoformans Rim101
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genes are not transcriptionally regulated by Rim101 is consistent
with our observation that the capsule defect is due to adherence,
not production.
Transcriptional profiling also suggested that Rim101 controls
the expression of several genes involved in iron or metal
homeostasis, including the iron transporter gene CFT1, side-
rophore importer gene SIT1, and copper transporter gene CTR4
[24,60–62]. In addition, we documented Rim101-dependent
expression of homologues of S. cerevisiae iron permeases (FRP1)
and reductases (FET3), which are known to be regulated by PKA
and by the Cryptococcus transcription factor Cir1 [60,61,63,64]. To
demonstrate that decreased expression of these genes was
biologically relevant, we incubated the rim101D mutant strain in
low iron medium, and we observed a distinct growth defect
compared to wild-type or the reconstituted RIM101 strain
(Figure 5A). C. neoformans strains typically induce capsule in
response to growth in this medium. Although the rim101D mutant
strain grew slowly in low iron media, it eventually reached
saturation phase. However, even when grown to saturation, the
rim101D mutant strain did not exhibit capsule in low iron media
(data not shown). Further analysis of these iron homeostasis genes
revealed that the promoters of all of these iron regulating genes
contain the potential Rim101 consensus binding sequence
GCCAAG or the diverged sequence CCAAGAA, recognized by
the S. cerevisiae, C. albicans and A. nidulans Rim101 orthologs
[7,27,65]. These results indicate that C. neoformans Rim101 retains
conserved roles in regulating iron homeostasis and import.
Rim101 and virulence
The ability to produce capsule is important for the pathogenic-
ity of C. neoformans, and other capsule-deficient strains are severely
attenuated for virulence in animal models of cryptococcosis
[33,35,66–68]. In addition, the ability to obtain iron from the
host and to grow in low iron conditions is important for microbial
survival in the host [60,63,69]. We therefore hypothesized that the
hypocapsular rim101D mutant would be avirulent in animal models
of cryptococcosis. However, a recent manuscript in which the
Figure 3. Rim101 localization in mutant backgrounds. Rim101 localization is dependent on PKA and Rim20. The pattern of Gfp-Rim101
localization in the indicated strains was visualized by DIC and fluorescent microscopy at 636magnification and by confocal microscopy at 1006
magnification.
doi:10.1371/journal.ppat.1000776.g003
C. neoformans Rim101
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neoformans mutants suggested that the rim101D mutant strain might
be more virulent than wild-type [39]. We therefore tested the role
of Rim101 in C. neoformans pathogenicity. Female A/Jcr mice (10
per strain) were inoculated intranasally with 5610
5 CFU of the
wildtype, rim101D mutant, or rim101D+RIM101 complemented
strains. Mice were monitored for survival and sacrificed at
predetermined clinical endpoints predicting mortality (Figure 6A).
Table 2. Subset of Rim101-dependent gene expression in capsule-inducing conditions.
Category Gene ID Description
a Fold change (WT/rim101)
Metal homeostasis
CNC01660 cytokine inducing-glycoprotein CIG1 471.88
CNE04530 siderochrome-iron transporter SIT1 81.14
CNM02420 acidic laccase, putative FET3 20.75
CNM02430 ferric permease CFT1 16.59
CNG00950 metalloreductase 16.09
CND01080 copper uptake transporter CTR4 7.09
Cell Wall
CNA07540 mannoprotein MP88 25.98
CND03490 mannoprotein MP98 26.52
CNG04420 alpha-1,3-glucan synthase, AGS1 23.78
CNN00660 glucan 1,3 beta-glucosidase protein 22.07
Capsule biosynthesis
CNH00170 phosphomannomutase PMM1 3.19
CNL06460 UDP-glucose 6-dehydrogenase UGD1 2.87
CNF00920 mannosyltransferase CMT1 22.97
Other
CNA05130 sodium efflux pump ENA1 6.92
This list contains functionally annotated genes whose expression was at least 2-fold different in wild-type vs. rim101D mutant strain after incubation in capsule-inducing
media for 3 hrs. Complete data set of all genes differentially regulated in the rim101D mutant strain can be found in Table S1.
a. Annotations obtained from NCBI database (http://www.ncbi.nlm.nih.gov/) and BLAST searches (http://www.ncbi.nlm.nih.gov/blast/) with additional hand editing.
doi:10.1371/journal.ppat.1000776.t002
Figure 4. Western blot analysis of Rim101 in rim101 and pka1D mutant backgrounds. A. Rim101cleavage is dependent on PKA and Rim20.
Immunoprecipitated Gfp-Rim101 from rim101D+ Gfp-rim101, rim101D+ Gfp-rim101-S773A, pka1D+ Gfp-rim10, rim20D+ Gfp-rim101, and rim20D+
Gfp-rim101-S773A strains was immunoblotted using anti-GFP antibody. B. Rim101 is cleaved after induction in capsule media. Gfp-Rim101 was
immunoprecipitated from rim101D, rim101D+ rim101-S773A, rim20D+ Gfp-rim101, and rim20D+ Gfp-rim101-S773A cell lysates after incubation in
either YPD medium or the capsule-inducing medium DMEM at 30uC to mid-log phase. Samples were run on Bis-Tris gels and immunoblotted using
an anti-GFP antibody.
doi:10.1371/journal.ppat.1000776.g004
C. neoformans Rim101
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complemented strain resulted in complete mortality 18 and 19
days after infection respectively; there was no statistically
significant difference between the survival of these two groups
(p=0.13). Mice infected with the rim101D mutant strain
succumbed to the infection 16 days post-infection; this represents
a statistically significant decrease in survival compared to animals
infected with the wild-type strain (p,0.002). We repeated the
infection and sacrificed mice on day 2, day 9 and day 14 to
determine fungal burden in the lungs, spleen, and brain. In all
organs, we found no statistically significant difference in rates of
dissemination among the 3 inoculated strains.
The subtle but reproducible increased virulence of the rim101D
mutant cells in the inhalation model of C. neoformans infection may
be due to enhanced survival in the acidic environment of the
alveolar macrophage. We specifically tested intracellular survival of
the wild-type, rim101D mutant, and rim101D+RIM101 comple-
mentedstrains. Asdescribed previously,weco-cultured C.neoformans
strains with IFNc- and LPS-activated J774.1 macrophage-like cells
[70]. There was no significant difference in the phagocytosis index
of these strains by the macrophages, signifying that the altered
capsule in the rim101D mutant did not affect fungal cell uptake into
macrophages [71]. In contrast, the rim101D mutant cells demon-
strated increased intracellular survival (p,0.004) within macro-
phages when normalized against the wild-type (Figure 6B).
Discussion
Microbial pathogens use varied adaptive mechanisms to survive
the harsh conditions of the infected host. Cryptococcus neoformans
creates a polysaccharide capsule in response to host conditions
such as low iron and high CO2 concentrations [1,24]. The C.
neoformans genome contains a number of genes involved in the
biosynthesis of this capsule, and many of these genes are highly
transcriptionally regulated, at least partially in response to the
PKA pathway [38]. This led us to screen through the genome for
transcription factors that are potentially regulated by PKA, and we
previously found that the Nrg1 protein regulates capsule. Deletion
of the NRG1 gene resulted in a partial capsule reduction, and
mutation of the putative PKA phosphorylation consensus
sequence prevented full capsule induction. However, not all of
the transcriptionally regulated capsule genes appeared to be
targets for Nrg1, and many of the nrg1D mutant phenotypes were
not as severe as mutations in the more upstream components of
the cAMP pathway [37]. Therefore, we hypothesized that several
transcriptional regulators would control capsule gene induction in
response to the PKA pathway. Using a combination of bioinfor-
matic and phenotypic screening, we identified the C. neoformans
Rim101 protein as another potential novel PKA-dependent
transcriptional regulator of capsule genes.
We hypothesized that the C. neoformans Rim101 protein may be
a target of direct PKA phosphorylation due to the presence of a
consensus sequence for PKA phosphorylation at amino acid
positions 730–736. In contrast, the previously described C. albicans
and S. cerevisiae Rim101 proteins do not contain potential PKA
phosphorylation consensus sequences. However, there are multi-
ple ways in which PKA can regulate downstream targets,
including indirect activation of upstream regulatory proteins as
well as by occupying the chromatin of the target genes [72]. Our
bioinformatic approach, therefore, does not identify all of the
targets of PKA, but does allow us to potentially identify direct
targets of PKA phosphorylation.
To determine the relationship between Rim101 and PKA, we
used complementary genetic, biochemical, and protein localiza-
tion experiments. Our results suggest that PKA and Rim20 are
necessary for maintenance of Rim101 nuclear localization by
altering the cleavage of this transcription factor. Rim20 has been
previously implicated in the first cleavage of Rim101, by binding
to PEST domains, which are also present in C. neoformans Rim101
[43,45]. In contrast to the predominantly nuclear localization of
Rim101 in wild-type cells, we observed both nuclear and
cytoplasmic localization of this protein in the pka1 and rim20
mutant strain backgrounds. We also observed both nuclear and
cytoplasmic localization of the Rim101-S773A mutant protein
with a putative PKA phosphorylation consensus sequence
mutation. In addition, the GFP-tagged Rim101 protein in all of
these strains had decreased electrophoretic mobility when
compared to the rim101D+Gfp-RIM101 strain. The larger band
is not due to hyperphosphorylation as this mobility shift was not
reversed by treatment with phosphatase. Together, these data
indicate that both the cAMP/PKA pathway and the Rim pathway
Figure 5. Rim101 in low iron media. A. Rim101 is required for
growth in low-iron medium. Strains were incubated in low-iron medium
and growth was quantified by monitoring the absorbance of the
culture at 600 nm. B. The 59-untranslated regions of C. neoformans
genes involved in iron regulation were evaluated for the presence of
putative Rim101 binding sites (GCCAAG or CCAAGAA).
doi:10.1371/journal.ppat.1000776.g005
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localization.
In Aspergillus and Candida, PacC/Rim101 is activated by two
cleavage events, first mediated Rim20 and Rim13 and second by
the proteosome [43,45,53]. We demonstrate that C. neoformans
Rim101 activation may also occur in response to two protein
cleavage events, as the Rim101 protein is further cleaved from the
120kD form to a 70kD form in capsule inducing conditions. This
further cleavage was not observed when PKA1 or RIM20 were
disrupted, suggesting that the initial cleavage to 120 kD is
necessary for further processing and activation of Rim101. The
multiple smaller bands/laddering observed when PKA1 or RIM20
are disrupted may indicate altered proteosome-mediated process-
ing events, suggesting that both Pka1 and Rim20 are necessary to
cause appropriate proteosomal involvement and maintain the
balance between processing and degradation. This is consistent
with data from A. nidulans, where PacC is first converted by PalB
and PalA under alkaline conditions to a 53kD intermediate which
exposes the second processing site to the proteosome [53]. Hervas-
Aguilar et al. also demonstrated that phosphorylation can
accumulate on the 72 and 53kD PacC intermediates during
alkaline conditions and affect processing. This is consistent with
our results that PKA is involved in regulating processing of
Rim101 in C. neoformans, although there is large divergence in the
C-terminal and in the potential signaling motifs between these
orthologous proteins in these distantly related species. Interesting-
ly, capsule-inducing conditions are not alkaline and thus are not a
traditional activating condition for Rim101 proteins. Therefore,
CnRim101 may have acquired novel activating conditions in
order to respond to the specific host conditions experienced by
cryptococcal cells in vivo.
When we examined the targets of Rim101 transcriptional
activation, we found that many Rim101 downstream targets and
responses from other pathogenic fungi, such as C. albicans, are
conserved in C. neoformans. We demonstrated that CnRim101 is
important for growth under alkaline conditions in vitro. Using
comparative transcriptional profiling, we determined that ENA1,a
known downstream target of Rim101 in other fungal species,
Figure 6. Virulence analysis of the rim101D mutant strain. A. rim101D mutant strains are hypervirulent in the murine inhalation model of
cryptococcosis. AJc/r mice were inoculated intranasally with 5610
5cryptococcal cells and monitored for survival. B. rim101D mutant cells survive
better than wild-type within macrophages. The rim101D mutant and isogenic wild-type strains were co-incubated with J744.1 macrophage-like cells
previously activated by INF-gamma and LPS. Extracellular yeast cells were removed after one hour of co-incubation. After 24 hours of co-culture, the
macrophages were lysed with SDS, and surviving yeast cells were quantitatively cultured. To precisely control for the number of added cells, the
colony-forming units from each strain were normalized to that of wild-type cells. Data points represent the average of triplicate samples +/2
standard error.
doi:10.1371/journal.ppat.1000776.g006
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(Table 2). The promoter of the ENA1 gene also had a conserved
predicted Rim101 binding sequence, suggesting that it might be a
direct target of Rim101 in C. neoformans, unlike in S. cerevisiae, where
Rim101 regulates ENA1 through Nrg1 [37]. Idnurm et al. showed
that Ena1 is required for C. neoformans survival under alkaline
conditions, and that appropriate response to alkaline conditions is
necessary for virulence of C. neoformans [73]. Therefore, decreased
expression of ENA1 in the rim101D mutant strain may explain the
defect in alkaline growth of the rim101D mutant.
Extracellular pH is involved in regulating iron uptake genes
through the Rim101 pathway in C. albicans and S. cerevisiae
[3,5–7,15,23,25]. The relationship between iron homeostasis and
Rim101 is also conserved in C. neoformans. In order to determine
the mechanism for the rim101D mutant strain sensitivity to low
iron, we compared the transcriptional profile between wild-type
and the rim101D mutant strain after incubation in capsule-inducing
conditions. Our microarray analysis concluded that a number of
iron homeostasis genes are differentially regulated between the
rim101D mutant and the wild-type and we confirmed these
alterations in gene expression using quantitative real-time PCR.
When we examined the putative promoter regions of the
candidate genes, we discovered potential Rim101 consensus
binding sequences in CFT1, FET3, and SIT1 among others,
suggesting these genes are direct targets of Rim101. Similarly, in
C. albicans, Rim101 binds directly to the promoter region of the
ferric reductase genes FRE1 and FRP1 to cause increased
transcription under iron-limited environments [23].
In C. neoformans, iron uptake is regulated by two pathways: PKA
and Cir1. Transcriptional profiling showed that many iron genes,
such as the iron permease Cft1 and reductase Cfo1 are
differentially regulated by PKA [24,26,60,61]. We have demon-
strated that Rim101 is regulated by PKA, thus providing a
mechanism for PKA regulation of these iron genes. However, in
our transcriptional profiling, we did not demonstrate any
difference in expression of Cir1 in the rim101D mutant strain,
further suggesting that there are two pathways that regulate iron
homeostasis. In C. albicans, two signaling pathways regulate iron
homeostasis in response to different forms of iron limitation. In C.
albicans, the ferric reductase gene FRP1 is differentially regulated
by Rim101 and by CBF transcription factors in response to
different forms of iron limitation [23]. It is possible that C.
neoformans has a similar set of transcription factors to regulate the
expression of these iron homeostasis genes under different iron-
limiting environments, and that the cell uses both Cir1 and
Rim101 to regulate the expression of Cft1 under different
environmental stimuli and iron source limitations.
Despite the decreased surface capsule observed in the rim101D
mutant cells when stained with India ink, this strain was still able
to secrete glucuronoxylomannan (GXM) at a similar size and
concentration as wild type when the cells were grown in capsule
inducing conditions. This data does not preclude other differences
in structure and modifications to the GXM in the mutant strain. In
accordance with the amount of secreted polysaccharide from the
rim101D mutant strain, our transcriptional profiling revealed that
few capsule biosynthesis genes are transcriptionally regulated by
Rim101. In the rim101D mutant strain we observed decreased
expression of UDP-glucose dehydrogenase Ugd1, mannosyltrans-
ferase Cmt1, and phosphomannomutase [55–58]. Unlike the iron
uptake genes, these capsule biosynthesis genes do not have
conserved Rim101 binding sites in the promoter regions,
suggesting that these are not direct targets of Rim101. Therefore,
our data indicates that CnRim101 is required for the transcrip-
tional activation of some genes involved in capsule biosynthesis;
however, the most important effects of Rim101 on capsule are
likely due to changes in polysaccharide binding to the cell surface.
We hypothesize that Rim101 regulates capsule by altering the
expression of genes responsible for anchoring capsule to the cell
wall, rather than acting as a direct regulator of these capsule
biosynthesis genes.
Unexpectedly for an acapsular strain, the rim101D mutant
displayed no attenuation in virulence in the mouse inhalation model
of cryptococcosis. This confirms prior broad screening experiments
of C. neoformansmutants to identify genes required for survival within
mice [39]. In these studies, the rim101D strain was slightly more
virulent than wild-type, as we demonstrated here. Follow-up
experiments determining fungal load in the brain, lung, and spleen
showed no defects in dissemination. When Rim101 is mutated in
Candida, the resulting strains are avirulent as Rim101 regulates
processes necessary for fungal virulence [3,14,19]. In a fungal
pathogen of plants, Fusarium oxysporum, a rim101D mutant strain is
more virulent than wild-type due to the derepression of acid
response genes conferring a survival advantage in the acidic host
environment of the tomato [2].Similarly, our data indicates that the
C. neoformans rim101D mutant grows better than wild-type within the
acidicphagolysosomeof the activated macrophage [29,74]. Perhaps
the derepression of acid responsive genes in the rim101D mutant
could explain the increased growth withinthe acidic phagolysosome
and thus within the lungs of the infected host. Another explanation
for the retained virulence of the rim101D mutant strain is that the
capsular polysaccharide may be shed into the surrounding tissues.
This capsular material has well defined immunosuppressant effects.
Capsular polysaccharide has even recently been used as an
experimental therapy for autoimmune diseases such as rheumatoid
arthritis [75]. Therefore,the retained virulence may be attributedto
theprofound immunomodulatory effects of strains that produce and
secrete large amounts of capsule. Also, not all capsule-defective C.
neoformans strains are hypovirulent in model systems. The acapsular
ags1D mutant is fully virulent in the nematode model of
cryptococcosis, although sensitive to temperature and thus avirulent
in the mouse [49,50]. The virulence of these strains suggests that
capsule may be playing an important role in suppressing the
immune system, even when not bound to the cell as an anti-
phagocytic mechanism.
It is also possible that the hypocapsular rim101D mutant may
present an altered cell surface for immune recognition, exposing
different antigens resulting in a substantively different immune
response than for an encapsulated WT strain. In this model, the
increased virulence might result from alterations of the exposed C.
neoformanssurfaceantigensleading to over-stimulation of the immune
system, such as seen in the response to b-glucan in the C. albicans cell
wall [76,77]. In our microarray data we observed increased
expression of MP88 and MP98, two immuno-dominant mannopro-
teins, in the rim101D mutant strain, further supporting a model of an
altered antigen surface on the fungus as a result of absent Rim101
activity [78,79]. MP88 has also been documented as having
increased expression in a pka1D mutant strain, which may be due
to decreased Rim101 activity [60]. A more detailed evaluation of the
nature of this cellular infiltration into the infected lungs will help
define the varied immune response to different C. neoformans strains.
In summary, we have demonstrated that the C. neoformans
Rim101 transcription factor retains conserved functions with
orthologous proteins from other fungal species, such as regulation
of pH response, cell wall formation, and iron homeostasis.
However, the phenotypic output resulting from a C. neoformans
Rim101 mutation supports the hypothesis that this conserved
protein has been co-opted for unique, species-specific function. In
contrast to other fungal species such as Candida or Aspergillus that
C. neoformans Rim101
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Rim101 as an inducing signal for virulence, C. neoformans may be
better adapted for acidic microenvironments in the host, such as
the macrophage phagolysosome. Moreover, our experiments
demonstrating PKA regulation of CnRim101 further suggests
that conserved signaling elements can be regulated in novel ways
to allow adaptation of microorganisms to specific niches in the
environment of the infected host.
Materials and Methods
Strains and media
Cryptococcus neoformans strains used in this study are listed in
Table 1. All C. neoformans strains were created in the H99 strain
background unless otherwise stated. Strains were maintained on
YPD (1% yeast extract, 2% peptone, 2% glucose), a standard yeast
medium. Selective media contained nourseothricin (100 mg/L
Werner BioAgents, Jena-Cospeda, Germany) or neomycin (G418)
(200 mg/L Clontech, Takara-Bio Inc.). Capsule inducing medium
(Dulbecco’s modified Eagle’s media with 25 mM NaHCO3) was
prepared as previously described [31]. YNB media (0.67% yeast
nitrogen base without amino acids, 2% glucose) was prepared as
previously described [33]. Alkaline pH media were created by
buffering YNB with 25 mM NaMOPS and adjusting to target pH
with NaOH. Resistance to hydrogen peroxide was tested by disc
diffusion as described previously [28]. Niger seed agar was
prepared from 70 g Niger seed extract (Niger seed pulverized
and boiled for 15 min and filtered through cheesecloth) and 4%
Bacto agar as previously described [33].
Molecular biology techniques
Standard techniques for Southern hybridization were per-
formed as described [80]. C. neoformans genomic DNA for Southern
blot analysis was prepared using CTAB phenol-chloroform
extraction as described [81].
Gene disruption
The wild-type RIM101 gene (NCBI GeneID CNH0097) was
mutated using biolistic transformation and homologous recombi-
nation with a rim101::nat mutant allele in which the entire RIM101
coding region was precisely replaced with the nourseothrycin
resistance gene (nat) [82,83]. The rim101::nat mutant allele was
created using PCR overlap extension as described [84]. Several
rim101D mutants from independent transformation events dis-
played identical phenotypes in vitro; therefore one strain (TOC2)
was chosen as the rim101 strain for the presented experiments.
Putative deletion strains were confirmed by PCR and Southern
blot analysis. A second rim101D strain was made by creating an
identical rim101D disruption construct first created by Liu et. al
[39] and biolistic transforming it into the H99 strain background.
This strain has a partial deletion of the RIM101 gene. Putative
mutant strains were confirmed by PCR and Southern blot
analysis, and phenotypically compared to the full TOC2 deletion
strain.
To reconstitute the wild-type allele, the RIM101 locus was
amplified from the H99 wild-type strain using primers (59
CTGTATCCTTCACTTGAGGC 39) and (59 AGCTGTGCG-
TATCCAATAAT 39). The neomycin resistance allele was also
amplified separately using the M13 forward and reverse primers
and both alleles were transformed using biolistic transformation
into strain TOC2 to make the reconstituted strain TOC4 as
described previously [85]. The reconstituted strain was tested by
PCR for presence of the wild-type allele, and examined for
reversion of the mutant phenotypes.
The wild-type RIM20 allele (NCBI GeneID CNG00250) was
similarly mutated with a rim20::nat mutant allele created by PCR
overlap extension. Several rim20D mutants from independent
transformation events displayed identical phenotypes in vitro;
therefore one strain (TOC14) was chosen as the rim20 strain for
the presented experiments. This strain was confirmed using PCR
and Southern analysis.
Protein localization/GFP fusion
We created a green fluorescent protein (Gfp)-Rim101 fusion
protein toexamine the subcellular localization ofRim101.A histone
H3 promoter-GFP fusion [86] was cloned into the neomycin-
resistance containing plasmid pJAF, utilizing BamHI and EcoRI to
make the resulting plasmid, pCN50. The coding region and the
terminator sequence of RIM101 was amplified using primers
modified with BamHI sites (59-AGTTAGGATCCATGGCT-
TACCCAATTCTCCC-39 and 59-ACTGATGGATCCGAGG-
AAAGCGTCAAGGATATG-39). The RIM101 gene was then
cloned into the pCN50 plasmid at the BamHI site to create the
plasmid pTO2 in which the Gfp-Rim101 fusion protein is
constitutively expressed under the His3 promoter. pTO2 was then
biolistically transformed into C. neoformans strain TOC2, JKH7,
CDC7, and TOC17 as previously described to create strains
TOC10, TOC12, TOC13 and TOC21 respectively. pTO2 was
mutated into pTO3 using PCR-mediated site-directed mutagenesis
to change serine 773 to alanine, using primers 59-GAGAGT-
GATGCCGCACGTCGATACTGTCCTG-39 and 59- AGT-
TAAGATCTATGGCTTACCCAATTCTCCC-39. pTO3 was
then biolistically transformed into TOC2, CDC7 and TOC17 to
create strains TOC18, TOC20 and TOC22 respectively.
Microscopy
Bright field, differential interference microscopy (DIC) and
fluorescent images were captured with a Zeiss Axio Imager.A1
fluorescent microscope equipped with an AxioCam mrM digital
camera.Confocal images were captured using a Zeiss LSM inverted
confocal microscope with the Argon/2 488 laser at6100 magnifi-
cation.To visualize capsule, cells weregrown ininducing conditions
(described above), then stained with India ink on glass slides. Images
were collected at 663 magnification. To visualize GFP, cells were
washed three times in PBS, and images were collected at 663
magnification, using 488 nm wavelength for fluorescence. The
strains exhibited significant artifactual fluorescence signal when
fixed and DAPI stained, therefore all fluorescence images were
taken without fixing, precluding DAPI staining.
Capsule blotting
Estimation of shed capsule polysaccharide size and amount was
performed using a technique described by Yoneda and Doering
[47]. Conditioned media was made by growing strains in
Dulbecco’s modified Eagle’s medium or low iron medium for 1
week at 30uC with shaking. The cells were incubated at 70uC for
15 minutes to denature enzymes, then pelleted for 3 minutes at
1500 rpm. The resulting supernatant was sterile filtered using a
0.2u filter. 15 uL of conditioned media was mixed with 6x load-
ing dye and run on an agarose gel at 25V for 15 h. The
polysaccharides were then transferred to a nylon membrane using
Southern blotting techniques. The membrane was air-dried and
blocked using Tris-Buffered Saline-Tween-20 (TBS-t) with 5%
milk. To detect the polysaccharide, the membrane was incubated
with monoclonal antibody 18b7 (1/1000 dilution) [87], washed
with TBS-t, then incubated with an anti-mouse peroxidase-
conjugated secondary antibody (1/25,000 dilution, Jackson Labs)
C. neoformans Rim101
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tivity Substrate (ThermoScientific).
Protein extraction, immunoprecipitation and western
blot analysis
Protein extracts were obtained using a method previously
described [88]. Briefly, cells were incubated to an optical density at
600 nm of 1 in YPD and capsule-inducing conditions. Twenty-
milliliter samples of growing cells were pelleted and resuspended in
0.5 mL of lysis buffer containing 2x protease inhibitors (Complete,
Mini, EDTA-free; Roche) and 2x phosphatase inhibitors (Phos-
Stop; Roche). To lyse the cells, the supernatant was removed and
the cells were lysed by bead beating (0.5 mL of 3uM glass beads in
a Mini-BeadBeater-16 (BioSpec), 4 cycles for 30 s each). Following
lysis, the samples were immunoprecipitated using 1.6mg anti-GFP
antibody (Roche) for 1 hour, then rotated with 80mL protein G
Sepharose (Thermo Scientific) for 1 hour. After washing, the
samples were eluted by the addition of 40mL 5x Laemmli sample
buffer and boiling. Western blots were performed as described
previously, using NuPAGE Tris-Acetate gels or NuPAGE Bis-Tris
gels to separate the samples. To detect the GFP-labeled proteins,
the blots were incubated with anti-GFP primary antibody (1/5,000
dilution) and an anti-mouse peroxidase-conjugated secondary
antibody (1/25,000 dilution, Jackson Labs). As a control for non-
specific immunoprecipitation, samples were tested in a mock IP (in
which no antibody was added) and probed with the anti-GFP
antibody, and no bands were observed in this control experiment.
RNA and cDNA preparation
Strains were incubated to mid-logarithmic phase in YPD then
washed three times with sterile water before incubation in capsule-
inducing media for 3 hours. Cells were washed three times before
centrifugation and freezing on dry ice and lyophilizing. RNA was
prepared from lyophilized samples using the RNeasy kit (Qiagen).
cDNA for real time-PCR was generated using RETROscript
(Ambion) using oligo-dT primer. Quantitative real-time PCR was
performed as previously described, using the constitutive GPD1
gene to normalize the samples [37].
Microarray and data analysis
The microarray used in this study was developed by the
Cryptococcus Community Microarray Consortium with financial
support from individual researchers and the Burroughs Wellcome
Fund (http://genome.wustl.edu/services/microarray/cryptococcus_
neoformans). RNAlabeling and hybridization were performed by the
Duke University Microarray Core Facility according to their
established protocols for custom spotted arrays [37,89]. Data was
analyzed using JMP genomics (SAS institute, Cary NC) and initial
background subtraction was performed. We used ANOVA normal-
ization and FDR analysis to calculate differences between treatment
effects for pairs of inducing conditions. Genes were considered for
further evaluation if they showed log2-transformed fold changes with
a p-value ,0.02.
Virulence and data analysis
The virulence of the C. neoformans strains was assessed using
a murine inhalation model of cryptococosis as described pre-
viously [70]. 10 female A/Jcr mice were inoculated intranasally
with 5610
5 C. neoformans cells of wild-type (H99), rim101Dmutant
(TOC2), or rim101+RIM101 complemented strain (TOC4). Mice
were monitored daily for signs of infection and were sacrificed at
predetermined clinical endpoints predicting mortality.
The statistical significance between the survival curves of all
animals infected with each strain was evaluated using the log-rank test
(JMP software, SAS institute, Cary NC). Cell counts were analyzed
using Student’s t-test. All studies were performed in compliance with
the institutional guidelines for animal experimentation.
Survival within alveolar macrophage-like J744.1 cells was tested
by aliquoting 50 ul of 1610
5 macrophage cells/mL into wells in a
96-well plate.Thecells were activatedby addingLPSand INFc and
incubating overnight. 50 ul of 2610
6cells/mL of each cryptococcal
strain were added to the wells and co-incubated for 1 hour after
which the excess cells were removed and fresh media was added.
The engulfed cells were incubated for 24 hours then disrupted with
0.5% SDS for 5 minutes to lyse the macrophages. The media was
removed, and the well was washed 26 with 100 uL PBS. The
washes were combined and diluted at 1:100 before plating. Plates
were incubated for 2 days before colony counts [70].
Supporting Information
Table S1 Complete data set of all genes differentially regulated
in the rim101 mutant strain
Found at: doi:10.1371/journal.ppat.1000776.s001 (0.88 MB
DOC)
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